MedTrace Logo

Neural Mobilization After Upper Extremity Fatigue in Amateur Athletes

NCT07682103 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2026-07-02

No results posted yet for this study

Summary

This randomized controlled trial evaluated the acute effects of neural mobilization and dynamic stretching after upper extremity fatigue on upper extremity performance and hand-eye coordination in amateur athletes. Participants were amateur athletes aged 18 to 25 years who regularly participated in sports involving active use of the upper extremity. After baseline assessment, all participants completed a standardized upper extremity fatigue protocol. They were then randomly allocated to one of three groups: neural mobilization, dynamic stretching, or passive rest. Outcomes were assessed at baseline, immediately after fatigue, and after the assigned recovery intervention or rest period. The study aimed to determine whether active recovery strategies, particularly neural mobilization, provide greater short-term recovery of upper extremity performance and hand-eye coordination compared with passive rest.

Conditions

  • Exercise-Induced Upper Extremity Fatigue
  • Hand-Eye Coordination
  • Athletic Performance

Interventions

OTHER

Neural Mobilization

Upper extremity neural mobilization was applied after the standardized fatigue protocol. The intervention targeted the median, radial, and ulnar nerves using non-painful mobilization techniques. Each technique was performed for 2 sets of 20 repetitions, with each repetition lasting approximately 1 to 3 seconds

OTHER

Dynamic Stretching

A structured dynamic stretching protocol was performed after the standardized fatigue protocol. The protocol lasted approximately 10 minutes and included dynamic upper extremity and whole-body movements such as arm swings, arm crossovers, walking lunges with trunk rotation, lateral shuffling, heel kicks, inchworms, and modified shuttle movements.

Sponsors & Collaborators

  • Uludag University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-12-19
Primary Completion
2026-05-28
Completion
2026-05-29

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07682103 on ClinicalTrials.gov